Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice
Open accessAbstract
Oxytocin sets the stage for childbirth by initiating uterine contractions, lactation and maternal bonding behaviours. Mice lacking secreted oxcytocin ( Oxt −/− , Cd38 −/− ) or its receptor ( Oxtr −/− ) fail to nurture. Normal maternal behaviour is restored by peripheral oxcytocin replacement in Oxt −/− and Cd38 −/− , but not Oxtr −/− mice, implying that circulating oxcytocin crosses the blood-brain barrier. Exogenous oxcytocin also has behavioural effects in humans. However, circulating polypeptides are typically excluded from the brain. We show that oxcytocin is transported into the brain by receptor for advanced glycation end-products (RAGE) on brain capillary endothelial cells. The increases in oxcytocin in the brain which follow exogenous administration are lost in Ager −/− male mice lacking RAGE, and behaviours characteristic to abnormalities in oxcytocin signalling are recapitulated in Ager −/− mice, including deficits in maternal bonding and hyperactivity. Our findings show that RAGE-mediated transport is critical to the behavioural actions of oxcytocin associated with parenting and social bonding.
AI snapshot
Written from the paper’s full text.
TL;DR
RAGE on brain capillary endothelial cells binds and transports peripheral oxytocin across the blood-brain barrier. Ager−/− mice lack brain oxytocin increases after peripheral oxytocin and show maternal neglect and hyperactivity, which endothelial RAGE re-expression rescues.
Key findings
- Oxytocin binds RAGE directly: surface plasmon resonance gave an apparent KD of 179 nM for oxytocin binding to immobilised human esRAGE; oxytocin co-eluted with soluble RAGE in human serum and was structurally confirmed by LC-MS/MS. Binding mapped to the RAGE V domain and did not activate NF-κB, Rac1, or Cdc42 signalling.
- Endothelial RAGE is necessary and sufficient for oxytocin transport into the brain: RAGE knockdown reduced blood-to-brain oxytocin transport in an in vitro BBB model; after subcutaneous oxytocin (30 ng/mouse), CSF oxytocin rose in WT but not Ager−/− male mice, and transgenic endothelial RAGE in Ager−/− mice restored CSF oxytocin. [13C,15N]oxytocin was undetectable in Ager−/− CSF but equivalent in WT and KO+Tg mice.
- Ager−/− mice recapitulated oxytocin-related behavioural deficits: maternal neglect reduced offspring survival, and endothelial RAGE re-expression rescued survival (63.4% KO+Tg vs 10.5% non-transgenic KO, P < 0.001). c-Fos increased after oxytocin in BNST, mPOA, AHC, and ILS of WT but not Ager−/− mice, and Ager−/− hyperactivity was normalised by intraventricular but not subcutaneous oxytocin.
- After bilateral common carotid artery occlusion, capillary RAGE increased ~2-fold and exogenous oxytocin increased in CSF of WT but not Ager−/− male mice. The estimated availability of oxytocin in CSF was 0.2% after subcutaneous administration of 30 ng oxytocin in mice.
Methods
- Mouse models included WT, Ager−/−, endothelial RAGE-transgenic Ager−/− (KO+Tg), and endothelial RAGE-deficient (EC-KO) mice; both male and female mice were used, with behavioural and maternal survival assays, BCCAO, and oxytocin administration by subcutaneous, intravenous, or intranasal routes.
- Binding and transport were assessed by surface plasmon resonance, plate binding/competition assays, gel permeation chromatography, anti-RAGE affinity chromatography, LC-MS/MS, and an in vitro BBB model using monkey brain capillary endothelial cells with rat pericytes and astrocytes, including RAGE shRNA knockdown, TEER, and Papp calculations.
- In vivo oxytocin was measured by enzyme immunoassay in serum, cisterna magna CSF, third-ventricle CSF, and microperfusates from amygdala and PVN; c-Fos immunohistochemistry and behavioural tests (light-dark transition, open field) were used, with statistics by t-test, ANOVA, and Kaplan–Meier survival analysis.
Limitations
- Stated: the exact bioavailability of oxytocin reaching the CNS remains unclear, and findings across studies are inconsistent due to differences in treatment protocols, species, and detection methods. The mechanism by which RAGE transports oxytocin is also unclear, though vesicular endocytosis/transcytosis is proposed.
- Stated: current experiments provide no evidence for direct intranasal transport via olfactory or trigeminal routes; instead, nasally applied oxytocin may enter the bloodstream and then be transported by RAGE. Oxytocin measurement is also method-dependent, and plasma extraction may lower measured levels.
- Evident: the maternal behaviour and hyperactivity experiments were conducted largely in male mice, while female mice were used mainly to show RAGE-mediated transport; human data are limited to serum binding/co-elution and do not test behaviour or causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 48 cited sources checked · 0 supported · 0 flagged
- Findingown data
Oxytocin binds soluble RAGE (esRAGE) with an apparent dissociation constant (KD) of 179 nM.
“Surface plasmon resonance methods showed concentration-dependent oxytocin binding to immobilised recombinant esRAGE, with an apparent dissociation constant (KD) of 179 nM (Fig. 1c).”
- Also stated in: § Oxytocin-RAGE interactions · plain
“Oxytocin-RAGE binding was further confirmed using plate assays where either oxytocin or esRAGE was immobilised, and esRAGE or oxytocin was in solution, respectively (Fig. 1d, e).”
Quote in the paperSubstantial claim - Also stated in: § Oxytocin-RAGE interactions · plain
- Findingown data
Endogenous oxytocin and soluble RAGE associate in human circulation.
“Endogenous oxytocin and soluble RAGE also associate in human circulation.”
- Also stated in: § Oxytocin-RAGE interactions · plain
“Using gel permeation chromatography to separate serum proteins based on molecular size, oxytocin immunoreactivity co-eluted with soluble RAGE (Supplementary Figure 1a).”
- Also stated in: § Oxytocin-RAGE interactions · plain
“Endogenous oxytocin in human serum (30 pmol/50 ml) also co-eluted with soluble RAGE following isolation by anti-RAGE antibody affinity chromatography (Supplementary Figure 1b).”
Quote in the paperSubstantial claim - Also stated in: § Oxytocin-RAGE interactions · plain
- Findingown data
RAGE is expressed in CD31-positive endothelial cells of the hippocampus and choroid plexus in WT but not Ager−/− mice.
“Immunohistochemical analyses showed RAGE in vascular patterns limited to CD31 (platelet endothelial cell adhesion molecule)-positive endothelial cells23, which are the components of the BBB, of the hippocampus and choroid plexus of WT (Fig. 3a, b) but not of Ager−/− mice (Supplementary Figure 4a).”
- Also stated in: § Oxytocin transport across the BBB · plain
“We also performed confocal microscopic analyses to observe RAGE expression in the circumventricular organs (CVOs) of the brain, referred to as ‘windows of the brain’, and found that RAGE expression was clearly observable in the endothelial cells of the neurohypophysis (Supplementary Figure 4b), but barely in those of the sensory CVOs, including the organum vasculosum of the lamina terminalis, subf”
Quote in the paperSubstantial claim - Also stated in: § Oxytocin transport across the BBB · plain
- Findingown data
Endogenous oxytocin in human serum is structurally indistinguishable from a synthetic oxytocin standard by LC-MS/MS.
“Analyses of the eluted fractions by liquid chromatography-tandem mass spectrometry (LC-MS/MS) showed that endogenous oxytocin in human serum is structurally indistinguishable from the synthetic oxytocin standard, as they eluted at identical times (Supplementary Figure 1d) and have identical parent ions (M+H+ 1008.2).”
Quote in the paperNot a substantial claim - Findingown data
RAGE co-localizes with caveolin-1 in endothelial cells and choroid plexus in WT mice.
“Further analysis revealed co-localisation of RAGE with cavelolin-1, a marker of plasma membrane invaginations (caveolae), in endothelial cells and the choroid plexus in WT mice (Supplementary Figure 4c), suggesting a role of RAGE in the oxytocin transfer (trafficking) through caveolae-associated endocytosis and transcytosis (Supplementary Figure 4d).”
Quote in the paperSubstantial claim
- Findingown data
Oxytocin increases in the amygdala and PVN of WT but not Ager−/− male mice following subcutaneous, intravenous, or intranasal administration.
“Microperfusion methods showed that oxytocin also increased in relevant regions of the brain, including the amygdala and PVN of the hypothalamus, of WT but not Ager−/− male mice following subcutaneous, intravenous or intranasal administration of oxytocin but not saline carrier (Fig. 4c, d and Supplementary Figure 5c).”
Quote in the paperSubstantial claim - Findingown data
Oxytocin receptors are not co-localized with endothelial cells in numerous sections of 5 brain regions of Venus mice expressing a fluorescent oxytocin receptor reporter.
“By contrast, oxytocin receptors, which could theoretically act as oxytocin transporters, were not co-localised with endothelial cells in numerous sections of 5 brain regions of Venus mice expressing a fluorescent oxytocin receptor reporter47 (Supplementary Figures 4e and f).”
Quote in the paperSubstantial claim - Findingown data
Following subcutaneous oxytocin, blood levels increase rapidly and return to baseline by 1-2 h in both WT and Ager−/− male mice.
“Steady-state levels in blood (~20 pg/ml) increased rapidly, peaking within 10 min after injection and returning to baseline by 1–2 h in both WT and Ager−/− male mice (Supplementary Figure 5a).”
Quote in the paperSubstantial claim - Findingown data
RAGE-mediated oxytocin transport occurs in female WT mice.
“Although oxytocin has been found to produce sex-specific effects48–50, RAGE-mediated oxytocin transport was also observed in female WT-mice (Fig. 4g).”
Quote in the paperSubstantial claim - Findingown data
After bilateral carotid occlusion, exogenous oxytocin increases in CSF of WT but not Ager−/− male mice.
“Nevertheless, exogenous oxytocin increased in the CSF of WT but not Ager−/− male mice after bilateral carotid occlusion (Fig. 5d and Supplementary Figure 5f).”
Quote in the paperSubstantial claim - Findingown data
Transgenic endothelial RAGE expression in Ager−/− mice rescues offspring survival (63.4% vs 10.5%).
“There was a substantial rescue of the Ager−/− phenotype, as 63.4% of the transgenic Ager−/− (KO + Tg) offspring survived, compared to only 10.5% survival for the non-transgenic Ager−/− (KO) offspring (P < 0.001) (Fig. 7a).”
Quote in the paperSubstantial claim - Findingown data
Offspring survival is lower in endothelial RAGE-deficient (EC-KO) mothers.
“In addition, offspring survival rate was lower in endothelial RAGE-deficient (EC-KO) mothers (P < 0.001; Fig. 7b).”
Quote in the paperSubstantial claim - Findingown data
Estimated availability of oxytocin in the CNF was 0.2% after subcutaneous administration of 30 ng oxytocin in mice.
“In our study, the estimated availability of oxytocin in the CNF was 0.2%, after subcutaneous administration of 30 ng oxytocin in mice, which was a much lower amount of oxytocin than used in previous studies.”
Quote in the paperSubstantial claim - Findingown data
Bilateral common carotid artery occlusion causes a ~2-fold increase in capillary RAGE.
“Using this method we found a ~2-fold increase in capillary RAGE (Fig. 5a, b).”
Quote in the paperSubstantial claim - Findingown data
Normal activity levels of WT mice are unaffected by subcutaneous or intraventricular oxytocin.
“Normal activity levels of WT mice were unaffected following administration of either subcutaneous or intraventricular oxytocin (Fig. 7c, d).”
Quote in the paperSubstantial claim - Findingown data
Oxytocin release from the hypothalamus is not affected by RAGE deficiency.
“Notably, OT release from the hypothalamus was not affected by the RAGE-deficiency (Supplementary Figure 6).”
Quote in the paperSubstantial claim - Premisecitation
Systemic loss of oxytocin or oxytocin receptors disrupts maternal nurturing behaviours in mice.
“Systemic loss of either oxytocin or oxytocin receptors (Oxt−/− and Oxtr−/−) disrupts maternal nurturing behaviours in mice7,8.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Insel, T. R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65, 768–779 (2010). source
Not checked in the free run.
- cites [8] Rilling, J. K. & Young, L. J. The biology of mammalian parenting and its effect on offspring social development. Science 345, 771–776 (2014). source
Not checked in the free run.
- Premisecitation
Many peripheral peptides and proteins do not pass freely into the central nervous system.
“Because many peripheral peptides and proteins do not pass freely into the central nervous system (CNS)20,21, we hypothesised a specialised uptake mechanism for oxytocin to cross the blood-brain barrier (BBB) and gain access to the CNS.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [20] Ermisch, A. et al. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Endocrinol. Exp. 19, 29–37 (1985).
Not checked in the free run.
- cites [21] Pardridge, W. M. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metab. 32, 1959–1972 (2012). source
Not checked in the free run.
- Study design and conductown data
RAGE knockdown does not affect the integrity of the in vitro primate BBB, assessed by high transendothelial electrical resistance.
“The integrity of the in vitro primate “BBB” was unaffected by RAGE knockdown, assessed by high transendothelial electrical resistance (TEER) (Fig. 2d).”
Quote in the paperSubstantial claim - Interpretationown data
Oxytocin binds the V domain of RAGE at a site distinct from S100B, AGEs, amyloid β, or HMGB1.
“Oxytocin binding to soluble RAGE was blocked by addition of recombinant V domain, marginally inhibited by C1 domain, and not blocked by C2 domain (Supplementary Figure 3e), suggesting that oxytocin binds the V domain, but at a distinct site from S100B, AGEs, amyloid β or HMGB142,43.”
Quote in the paperSubstantial claim - Interpretationown data
Endothelial RAGE is required for oxytocin transport into the CNS.
“The direct CSF measures (Fig. 4a, b) and microperfusion results (Fig. 4c, d) confirm that oxytocin in the blood is transported across the BBB as suggested by Landgraf and his collegues16,17,20 and to our knowledge, show for the first time that endothelial RAGE is required for oxytocin transport into the CNS.”
- Also stated in: § Abstract · plain
“We show that oxcytocin is transported into the brain by receptor for advanced glycation end-products (RAGE) on brain capillary endothelial cells.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Interpretationown data
RAGE-mediated transport is critical to the behavioural actions of oxytocin associated with parenting and social bonding.
“Our findings show that RAGE-mediated transport is critical to the behavioural actions of oxcytocin associated with parenting and social bonding.”
- Also stated in: § Social behaviour in RAGE knockout mice · hedged
“These findings provide psychopharmacological support for the importance of vascular RAGE-dependent transport of peripheral oxytocin into the brain, which appears to be necessary for the development and maintenance of normal social behaviours.”
Quote in the paperSubstantial claim - Also stated in: § Social behaviour in RAGE knockout mice · hedged
- Premisecitation
Oxytocin activates c-Fos positive neurons.
“which are now known to activate c-Fos positive neurons51–53.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [51] Numan, M. & Numan, M. J. Projection sites of medial preoptic area and ventral bed nucleus of the stria terminalis neurons that express Fos during maternal behavior in female rats. J. Neuroendocrinol. 9, 369–384 (1997). source
Not checked in the free run.
- cites [52] Martinez, L. A., Levy, M. J. & Petrulis, A. Endogenous oxytocin is necessary for preferential Fos expression to male odors in the bed nucleus of the stria terminalis in female Syrian hamsters. Horm. Behav. 64, 653–664 (2013). source
Not checked in the free run.
- cites [53] Zhong, J. et al. c-Fos expression in the paternal mouse brain induced by communicative interaction with maternal mates. Mol. Brain 7, 66 (2014). source
Not checked in the free run.
- Premisecitation
Ager−/− male mice are known to be hyperactive, with greater speeds and distances travelled during both light-dark transition and open field tests.
“Ager−/− male mice are also known to be hyperactive, with greater speeds and distances travelled during both light-dark transition and open field tests58.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Sakatani, S. et al. Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice. PLoS One 4, e8309 (2009). source
Not checked in the free run.
- Interpretationreasoning
RAGE is required for normal physiological functioning of oxytocin.
“By contrast, our findings demonstrate that RAGE is required for normal physiological functioning of oxytocin, which may also be inhibited by these drug discovery strategies.”
Quote in the paperSubstantial claim
- May combine two claims. 18
- Classified as probably not a substantial claim. 19
May combine two claims.
Findingown dataOxytocin does not stimulate or inhibit RAGE-dependent NF-κB signaling and does not activate Rac1 or Cdc42 signaling.
“oxytocin neither stimulates a RAGE-dependent NF-κB reporter nor inhibits reporter induction by AGEs, a ligand that activates the NF-κB reporter22,27 (Supplementary Figure 2a).”
- Also stated in: § Oxytocin-RAGE interactions · plain
“Furthermore, oxytocin did not activate NF-κB-independent Rac1 or Cdc42 signalling, which are also suggested to function downstream of RAGE24,41,42 (Supplementary Figures 2b and 2c).”
Quote in the paperNot a substantial claim- Also stated in: § Oxytocin-RAGE interactions · plain
May combine two claims.
Findingown dataIn an in vitro BBB model, oxytocin transport is dose-dependent and is reduced selectively in the blood-to-brain direction following RAGE knockdown.
“Endothelial transport of oxytocin was dose-dependent (Fig. 2b) and of a similar rate to transport of centrally acting drugs46.”
- Also stated in: § Oxytocin transport across the BBB · plain
“Notably, oxytocin transport was reduced selectively in the blood-to-brain direction following RAGE knockdown (Fig. 2b).”
- Also stated in: § Oxytocin transport across the BBB · plain
“Reverse transport was much less efficient (Fig. 2e), and according to calculated apparent permeability (Papp) measures, inconsequential (Fig. 2f).”
Quote in the paperSubstantial claim- Also stated in: § Oxytocin transport across the BBB · plain
May combine two claims.
Findingown dataFollowing subcutaneous oxytocin, CSF oxytocin increases in WT but not Ager−/− male mice.
“By contrast, levels of oxytocin in CSF from the cisterna magna of WT mice increased more gradually to maxima at 1–2 h before returning to baseline at 4 h (Fig. 4a).”
- Also stated in: § RAGE-dependent transport of oxytocin across the BBB · plain
“Despite equivalently high serum levels following injection of identical amounts of oxytocin (Supplementary Figure 5a), concentrations in the CSF of Ager−/− mice remained at baseline levels (Fig. 4a).”
- Also stated in: § RAGE-dependent transport of oxytocin across the BBB · plain
“Following subcutaneous injection, oxytocin increased in third ventricle CSF of WT but not Ager−/− male mice (Fig. 4b and Supplementary Figure 5b).”
Quote in the paperSubstantial claim- Also stated in: § RAGE-dependent transport of oxytocin across the BBB · plain
May combine two claims.
Findingown data[13C,15N]oxytocin is undetectable in CSF of Ager−/− male mice but equivalent in WT and KO+Tg mice after subcutaneous injection.
“Following subcutaneous injection, [13C,15N]oxytocin was undetectable in CSF of Ager−/− male mice, whereas amounts in the CSF of WT or KO + Tg mice were equivalent (Fig. 4f and Supplementary Figure 5e).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTransgenic endothelial RAGE expression in Ager−/− mice restores CSF oxytocin to WT levels, while in WT mice it minimally affects CSF oxytocin.
“Tg expression in Ager−/− mice increased oxytocin in CSF to the WT concentration, whereas Tg expression in WT mice minimally affected CSF oxytocin concentrations (Fig. 4e and Supplementary Figure 5d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAger−/− male mice show hyperactivity that is normalized by intraventricular but not subcutaneous or nasal oxytocin.
“During light-dark transition tests, the greater distances travelled (c) and greater average speed (d) in the light zone exhibited by Ager−/− male mice were both reduced by intraventricular (V) but not subcutaneous (sc) injection of oxytocin (OT) (n = 14–16).”
- Also stated in: § Social behaviour in RAGE knockout mice · plain
“Concordantly, intraventricular but not nasal administration of oxytocin normalised distances travelled by Ager−/− mice in open field tests (Fig. 7e).”
Quote in the paperSubstantial claim- Also stated in: § Social behaviour in RAGE knockout mice · plain
May combine two claims.
Findingown dataSubcutaneous oxytocin increases c-Fos positive nuclei in BNST, mPOA, AHC, and ILS of WT but not Ager−/− male mice.
“Numbers of c-Fos positive nuclei increased after subcutaneous oxytocin administration in four distinct regions of the brain, the bed nucleus of the stria terminalis (BNST), medial preoptic area (mPOA), centre of the anterior hypothalamic area (AHC) and ventral portion of the intermediate lateral septal nucleus (ILS) (Fig. 6a, b).”
- Also stated in: § c-Fos as CNS actions of oxytocin · plain
“This is dependent on both oxytocin and RAGE, as there are no effects in Ager−/− male mice or when vehicle control was administered (Fig. 6b).”
Quote in the paperSubstantial claim- Also stated in: § c-Fos as CNS actions of oxytocin · plain
May combine two claims.
Findingown dataAger−/− pups have low survival due to maternal neglect; cross-fostering to WT mothers rescues survival, while WT pups with Ager−/− mothers do poorly.
“Survival of Ager gene null (Ager−/−) pups is often low due to maternal neglect, with even mild maternal stress leading to dramatic reductions in offspring survival (Fig. 1a).”
- Also stated in: § Oxytocin-RAGE interactions · boosted
“This is clearly a maternal deficit, as newborn Ager−/− pups transferred to wild-type (WT) post-partum mothers are nurtured and survive at near normal frequencies. By contrast, normal offspring of WT mothers do poorly when transferred to post-partum Ager−/− mothers (Fig. 1b).”
Quote in the paperSubstantial claim- Also stated in: § Oxytocin-RAGE interactions · boosted
May combine two claims.
Findingown dataMass spectrometry did not identify arginine-vasopressin in eluted material from immobilised esRAGE, and RAGE did not transport it in an in vitro BBB assay.
“Mass spectrometry of the eluted material from the immobilised esRAGE in human serum did not identify arginine-vasopressin; additionally, RAGE did not transport it in an in vitro blood–brain barrier (BBB) assay system (Supplementary Figure 7).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationOxytocin mediates physiological and psychosocial events surrounding mammalian birth, including uterine contractions, lactation, and maternal bonding.
“Oxytocin mediates both physiological and psychosocial events surrounding mammalian birth, including uterine contractions, initiation of lactation, and maternal bonding1,2.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Brunton, P. J. & Russell, J. A. The expectant brain: adapting for motherhood. Nat. Rev. Neurosci. 9, 11–25 (2008). source
Not checked in the free run.
- cites [2] Dulac, C., O’Connell, L. A. & Wu, Z. Neural control of maternal and paternal behaviors. Science 345, 765–770 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExogenous oxytocin has behavioural effects in humans, particularly in social deficit-related psychiatric disorders such as autism and schizophrenia.
“Exogenous oxytocin in humans also appears to have behavioural effects, particularly in such social deficit-related psychiatric disorders as autism and schizophrenia9–13.”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [9] Higashida, H., Yokoyama, S., Kikuchi, M. & Munesue, T. CD38 and its role in oxytocin secretion and social behavior. Horm. Behav. 61, 351–358 (2012). source
Not checked in the free run.
- cites [10] Insel, T. R. Translating oxytocin neuroscience to the clinic: A National Institute of Mental Health Perspective. Biol. Psychiatry 79, 153–154 (2016). source
Not checked in the free run.
- cites [11] Guastella, A. J. et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 67, 692–694 (2010). source
Not checked in the free run.
- cites [12] Gordon, I. et al. Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci. Rep. 6, 35054 (2016). source
Not checked in the free run.
- cites [13] Feifel, D., Shilling, P. D. & MacDonald, K. A review of oxytocin’s effects on the positive, negative, and cognitive domains of schizophrenia. Biol. Psychiatry 79, 222–233 (2016). source
Not checked in the free run.
May combine two claims.
PremisereasoningPeripheral oxytocin replacement restores normal maternal behaviour in Oxt−/− and Cd38−/− mice but not Oxtr−/− mice, implying that circulating oxytocin crosses the blood-brain barrier.
“Normal maternal behaviour is restored by peripheral oxcytocin replacement in Oxt−/− and Cd38−/−, but not Oxtr−/− mice, implying that circulating oxcytocin crosses the blood-brain barrier.”
- Also stated in: § Introduction · hedged
“This is restored by administration of exogenous oxytocin in Oxt−/− but not Oxtr−/− mice, suggesting that peripheral oxytocin has central effects.”
- Also stated in: § Introduction · plain
“Mice lacking CD38, a cyclic ADP ribose synthetase and hydrolase necessary for secretion of oxytocin, also display this characteristic behavioural phenotype, which is also reversed following administration of exogenous oxytocin5,9.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Jin, D. et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446, 41–45 (2007). source
Not checked in the free run.
- cites [9] Higashida, H., Yokoyama, S., Kikuchi, M. & Munesue, T. CD38 and its role in oxytocin secretion and social behavior. Horm. Behav. 61, 351–358 (2012). source
Not checked in the free run.
- Also stated in: § Introduction · hedged
Classified as probably not a substantial claim.
PremisecitationRAGE is not known to be related to oxytocin or oxytocin signalling.
“RAGE, a member of the immunoglobulin superfamily of pattern recognition receptors, is not known to be related to oxytocin or oxytocin signalling22–33.”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [22] Senatus, L. M. & Schmidt, A. M. The AGE-RAGE axis: implications for age-associated arterial diseases. Front. Genet. 8, 187 (2017). source
Not checked in the free run.
- cites [23] Kamide, T. et al. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem. Int. 60, 220–228 (2012). source
Not checked in the free run.
- cites [24] Manigrasso, M. B., Juranek, J., Ramasamy, R. & Schmidt, A. M. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol. Metab. 25, 15–22 (2014). source
Not checked in the free run.
- cites [25] Takuma, K. et al. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc. Natl Acad. Sci. USA 106, 20021–20026 (2009). source
Not checked in the free run.
- cites [26] Yamamoto, Y. et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108, 261–268 (2001). source
Not checked in the free run.
- cites [27] Yamamoto, Y. et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J. Immunol. 186, 3248–3257 (2011). source
Not checked in the free run.
- cites [28] Yamamoto, Y. & Yamamoto, H. RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front. Endocrinol. 4, 105 (2013). source
Not checked in the free run.
- cites [29] Yonekura, H. et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370, 1097–1109 (2003). source
Not checked in the free run.
- cites [30] Motoyoshi, S. et al. cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products. Biochem. J. 463, 75–82 (2014). source
Not checked in the free run.
- cites [31] Mackic, J. B. et al. Human blood-brain barrier receptors for Alzheimer’s amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734–743 (1998). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe three RAGE forms bind various ligands with similar affinities, including AGEs and amyloid β peptide.
“The three RAGE forms bind various ligands with similar affinities, including multiple advanced glycation end-products (AGEs) and amyloid β peptide31–37.”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [31] Mackic, J. B. et al. Human blood-brain barrier receptors for Alzheimer’s amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734–743 (1998). source
Not checked in the free run.
- cites [32] Yamamoto, Y. et al. Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells. Diabetes Res. Clin. Pract. 77, S30–S40 (2007). source
Not checked in the free run.
- cites [33] Matsumoto, K. et al. Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain. Histochem. Cell. Biol. 144, 597–611 (2015). source
Not checked in the free run.
- cites [34] Deane, R. et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907–913 (2003). source
Not checked in the free run.
- cites [35] Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377–1392 (2012). source
Not checked in the free run.
- cites [36] Saito, R., Araki, S., Yamamoto, Y. & Kusuhara, K. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children. J. Pediatr. Endocrinol. Metab. 30, 63–69 (2017). source
Not checked in the free run.
- cites [37] Gasparotto, J. et al. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment. J. Biol. Chem. 293, 226–244 (2018). source
Not checked in the free run.
May combine two claims.
Study design and conductown dataBilateral common carotid artery occlusion does not cause fluorescein to leak into the CSF, suggesting no generalised increase in vascular permeability.
“As a control, we showed this procedure does not cause fluorescein to leak into the CSF (Fig. 5c), suggesting there is not a generalised increase in vascular permeability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitationc-Fos positive neurons are activated during the acquisition of postpartum maternal behaviours.
“The classical studies of Numan showed c-Fos positive neurons are activated during the acquisition of postpartum maternal behaviours51.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Numan, M. & Numan, M. J. Projection sites of medial preoptic area and ventral bed nucleus of the stria terminalis neurons that express Fos during maternal behavior in female rats. J. Neuroendocrinol. 9, 369–384 (1997). source
Not checked in the free run.
May combine two claims.
Interpretationown dataRAGE is both necessary and sufficient for oxytocin transport into the brain in both male and female mice.
“These results demonstrated that RAGE is both necessary and sufficient for oxytocin transport into the brain in both male and female mice.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRAGE is being targeted for inhibition in drug discovery efforts.
“Since both of these are deleterious, pathological effects, RAGE is being targeted for inhibition in drug discovery efforts35.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377–1392 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRAGE has been shown to transport amyloid β peptide across the blood-brain barrier, promoting Alzheimer disease-like symptoms in susceptible mice.
“For example, RAGE has been shown to transport amyloid β peptide across the BBB, which promotes Alzheimer disease-like symptoms in susceptible mice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe affinity of oxytocin binding to the oxytocin receptor has often been estimated to be KD ~100 nM, although a high affinity form with KD ~1 nM has also been reported.
“The affinity of oxytocin binding to the oxytocin receptor has often been estimated to be KD ~100 nM, although a high affinity form with KD ~1 nM has also been reported60.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Gimpl, G. & Fahrenholz, F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81, 629–683 (2001). source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of maternal nurturing and social interactive behaviours in Cd38−/− mice are restored following peripheral oxytocin, consistent with transport of peripherally administered oxytocin into the brain.
“Loss of maternal nurturing and social interactive behaviours in Cd38−/− mice have been restored following peripheral administration of oxytocin, consistent with transport of peripherally administered exogenous oxytocin into brain5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Jin, D. et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446, 41–45 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationLevels of oxytocin in the periphery are lower than those in the CSF in humans, providing a concentration gradient for transport.
“Levels of oxytocin in the periphery are lower than those in the CSF, in humans16,61,62, providing a concentration gradient for what appears to be a transport mechanism: this point of view depends on the methods of oxytocin measurements in blood, because a recent report has shown much higher blood OT levels than previously thought using a robust nanoLC-MS platform63.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [16] Striepens, N. et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 3, 3440 (2013). source
Not checked in the free run.
- cites [61] Kagerbauer, S. M. et al. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid. J. Neuroendocrinol. 25, 668–673 (2013). source
Not checked in the free run.
- cites [62] Martin, J. et al. Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage. Neuropeptides 48, 91–96 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationClinical studies have linked autism and Asperger's disorders and attention-deficit/hyperactivity disorders to oxytocin deficiency.
“Clinical studies have linked autism and Asperger’s disorders and attention-deficit/hyperactivity disorders to oxytocin deficiency7,8,54, and the potential use of exogenous oxytocin to treat these conditions is being assessed in clinical trials10,11,54–57.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7] Insel, T. R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65, 768–779 (2010). source
Not checked in the free run.
- cites [8] Rilling, J. K. & Young, L. J. The biology of mammalian parenting and its effect on offspring social development. Science 345, 771–776 (2014). source
Not checked in the free run.
- cites [54] Feldman, R. et al. Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes. Biol. Psychiatry 72, 175–181 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenRAGE is implicated in the pathogenesis of diabetes complications.
“RAGE has also been implicated in the pathogenesis of diabetes complications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe oxytocin assay had two linear ranges: a lower concentration range from a few to 30 pg/ml, and a higher concentration range between 50 and 1000 pg/ml.
“The oxytocin assay had two linear ranges, which covers a lower concentration range from a few to 30 pg/ml, and a higher concentration range between 50 and 1000 pg/ml.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll animal experiments were approved by the Committee on Animal Experimentation of Kanazawa University and performed in accordance with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan.
“All animal experiments were approved by the Committee on Animal Experimentation of Kanazawa University and performed in accordance with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationCSF was collected according to the protocol for sampling CSF from mice without detectable plasma contamination.
“CSF was collected according to the protocol for sampling CSF from mice without detectable plasma contamination77,78.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [77] Lopatina, O. et al. H. Communication impairment in ultrasonic vocal repertoire during the suckling period of Cd157 knockout mice: transient improvement by oxytocin. Front. Neurosci. 11, 266 (2017). source
Not checked in the free run.
- cites [78] Liu, L. & Duff, K. A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J. Vis. Exp. 21, pii: 960 (2008).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAn additional extraction step may have resulted in lower than actual oxytocin levels.
“whereas an additional extraction step may have resulted in lower than actual oxytocin levels.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe inter-assay and intra-assay coefficients of variation of the oxytocin assay were less than 15%.
“The inter-assay and intra-assay coefficients of variation were less than 15%.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIn the cerebral ischaemia model, mice that exhibited <15% of the baseline control microperfusion during the first minute of occlusion were used in subsequent experiments.
“In our experimental model, the mice that exhibited <15% of the baseline control microperfusion during the first minute of occlusion were used in subsequent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe in vitro BBB models were established within 4 days of seeding the cells according to the manufacturer's instructions.
“The in vitro BBB models were established within 4 days of seeding the cells according to the manufacturer’s instructions46.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Nakagawa, S. et al. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 27, 687–694 (2007). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenUnextracted samples result in binding of complexes of oxytocin stuck to interacting proteins.
“though unextracted samples result in binding of complexes of oxytocin stuck to interacting proteins.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe open field test is meant to assess anxious behaviour.
“The open field test is meant to assess anxious behaviour80.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Zhong., J. et al. Cyclic ADP-ribose and heat regulate oxytocin release via CD38 and TRPM2 in the hypothalamus during social or psychological stress in mice. Front. Neurosci. 10, 304 (2016). source
Not checked in the free run.
- Rests on an assumption: Mice naturally prefer to be near protective walls rather than being exposed to potential dangers in open spaces.
The paper relies on this without support.
Mice naturally prefer to be near protective walls rather than being exposed to potential dangers in open spaces.
“This test is based on the idea that mice naturally prefer to be near protective walls rather than being exposed to potential dangers in open spaces.”
The paper relies on this without support.
Sodium fluorescein (MW 376.3) does not cross an intact blood-brain barrier.
“Sodium fluorescein (MW 376.3) is a fluorescent tracer that does not cross an intact BBB.”
The paper relies on this without support.
Trans-endothelial electrical resistance (TEER) primarily reflects the flux of sodium ions through the cell layers in the culture conditions.
“Trans-endothelial electrical resistance (TEER), which primarily reflects the flux of sodium ions through the cell layers in the culture conditions, was measured with an epithelial-volt-ohm metre and an Endohm-6 chamber electrodes (World Precision Instruments, Sarasota, FL, USA).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bypassing the blood-brain barrier remains a perennial problem for pharmacological interventions including IN-OT.
“However, bypassing the blood-brain barrier remains a perennial problem for pharmacological interventions including IN-OT”
From Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry (2021) · cites this paper as [70]
There are questions surrounding IN-OT's ability to cross the blood-brain barrier and diffuse to subcortical structures.
“and there are questions surrounding its ability to cross the blood-brain barrier and diffuse to subcortical structures [70,71]”
From Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry (2021) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Intranasal oxytocin concentration differs between figure and methods
MajorThe Fig. 7e caption specifies 100 ng/ml for nasal administration, whereas the administration method specifies 1000 ng/ml for the same 20 μl volume.
“nasal (100 ng/ml × 20 μl) administration of oxytocin (OT)”
“Synthetic oxytocin (1000 ng/ml × 20 μl) was administered nasally;”
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · see citing works
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994 · see citing works
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426 · see citing works
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130 · see citing works
Insel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044 · see citing works
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962 · see citing works
Neumann, I. D., & Landgraf, R. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.08.004 · Cited by 954 · see citing works
Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice
Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806 · see citing works
Self-citationYONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716 · see citing works
Self-citationCD38 is critical for social behaviour by regulating oxytocin secretion
Jin, D., Liu, H.-X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N. A., Yamada, K., Noda, M., Seike, T., et al. (2007) · Nature · doi:10.1038/nature05526 · Cited by 665 · see citing works
Self-citationDeane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619 · see citing works
Intranasal Oxytocin: Myths and Delusions
Leng, G., & Ludwig, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.003 · Cited by 615 · see citing works
Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5593-08.2009 · Cited by 608 · see citing works
Self-citationIncreased brain and plasma oxytocin after nasal and peripheral administration in rats and mice
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · see citing works
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475 · see citing works
Self-citationNeural control of maternal and paternal behaviors
Dulac, C., O’Connell, L. A., & Wu, Z. (2014) · Science · doi:10.1126/science.1253291 · Cited by 457 · see citing works
Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452 · see citing works
The biology of mammalian parenting and its effect on offspring social development
Rilling, J. K., & Young, L. J. (2014) · Science · doi:10.1126/science.1252723 · Cited by 452 · see citing works
The expectant brain: adapting for motherhood
Brunton, P. J., & Russell, J. A. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2280 · Cited by 407 · see citing works
Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 Genes
Feldman, R., Zagoory-Sharon, O., Weisman, O., Schneiderman, I., Gordon, I., Maoz, R., Shalev, I., & Ebstein, R. P. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.025 · Cited by 393 · see citing works
Nakagawa, S., Deli, M. A., Nakao, S., Honda, M., Hayashi, K., Nakaoke, R., Kataoka, Y., & Niwa, M. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9195-4 · Cited by 364 · see citing works
Neuroendocrine regulation of maternal behavior
Bridges, R. S. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.11.007 · Cited by 346 · see citing works
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., Haroon, E., Thompson, R., Ditzen, B., Patel, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.022 · Cited by 343 · see citing works
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P. K., & Abbott, N. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 304 · see citing works
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction
Takuma, K., Fang, F., Zhang, W., Yan, S., Fukuzaki, E., Du, H., Sosunov, A., McKhann, G., Funatsu, Y., Nakamichi, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905686106 · Cited by 290 · see citing works
Self-citationA Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
Liu, L., & Duff, K. (2008) · Journal of Visualized Experiments · doi:10.3791/960 · Cited by 268 · see citing works
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 248 · see citing works
Self-citationMackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242 · see citing works
The oxytocin system in drug discovery for autism: Animal models and novel therapeutic strategies
Modi, M. E., & Young, L. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.010 · Cited by 218 · see citing works
Kagerbauer, S. M., Martin, J., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12038 · Cited by 212 · see citing works
Unlocking the biology of RAGE in diabetic microvascular complications
Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.08.002 · Cited by 209 · see citing works
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002253 · Cited by 207 · see citing works
Self-citationPet-1 is required across different stages of life to regulate serotonergic function
Liu, C., Maejima, T., Wyler, S. C., Casadesús, G., Herlitze, S., & Deneris, E. S. (2010) · Nature Neuroscience · doi:10.1038/nn.2623 · Cited by 178 · see citing works
CSF and blood oxytocin concentration changes following intranasal delivery in macaque
Dal Monte, O., Noble, P. L., Turchi, J., Cummins, A., & Averbeck, B. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103677 · Cited by 177 · see citing works
Lundquist, S., Renftel, M., Brillault, J., Fénart, L., Cecchelli, R., & Dehouck, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1016462205267 · Cited by 173 · see citing works
Zhang, G., & Cai, D. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2011 · Cited by 171 · see citing works
The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
Senatus, L. M., & Schmidt, A. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00187 · Cited by 167 · see citing works
Numan, M., & Numan, M. J. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.t01-1-00597.x · Cited by 149 · see citing works
Sex-specific effects of stress on oxytocin neurons correspond with responses to intranasal oxytocin
Steinman, M. Q., Duque-Wilckens, N., Greenberg, G. D., Hao, R., Campi, K. L., Laredo, S. A., Laman-Maharg, A., Manning, C. E., Doig, I. E., Lopez, E. M., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.007 · Cited by 131 · see citing works
Castel, M., Gainer, H., & Dellmann, H. ‐. (1984) · International review of cytology · doi:10.1016/s0074-7696(08)62760-6 · Cited by 128 · see citing works
Bethlehem, R. A. I., Baron-Cohen, S., van Honk, J., Auyeung, B., & Bos, P. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00048 · Cited by 120 · see citing works
Gasparotto, J., Girardi, C. S., Somensi, N., Ribeiro, C. T., Moreira, J. C. F., Michels, M., Sonai, B., Rocha, M., Steckert, A. V., Barichello, T., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786756 · Cited by 120 · see citing works
Proteomics tools reveal startlingly high amounts of oxytocin in plasma and serum
Brandtzaeg, O. K., Johnsen, E., Røberg‐Larsen, H., Seip, K. F., MacLean, E. L., Gesquiere, L. R., Leknes, S., Lundanes, E., & Wilson, S. R. (2016) · Scientific Reports · doi:10.1038/srep31693 · Cited by 119 · see citing works
Gordon, I., Jack, A., Pretzsch, C. M., Vander Wyk, B., Leckman, J. F., Feldman, R., & Pelphrey, K. A. (2016) · Scientific Reports · doi:10.1038/srep35054 · Cited by 114 · see citing works
Opposing effects of oxytocin on moral judgment in males and females
Scheele, D., Striepens, N., Kendrick, K. M., Schwering, C., Noelle, J., Wille, A., Schlaepfer, T. E., Maier, W., & Hurlemann, R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22605 · Cited by 112 · see citing works
A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110 · see citing works
Lefevre, A., Mottolese, R., Dirheimer, M., Mottolese, C., Duhamel, J.-R., & Sirigu, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17674-7 · Cited by 105 · see citing works
(1985) · PubMed · Cited by 104 · see citing works
Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application
Tanaka, A., Furubayashi, T., Arai, M., Inoue, D., Kimura, S., Kiriyama, A., Kusamori, K., Katsumi, H., Yutani, R., Sakane, T., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00991 · Cited by 104 · see citing works
Leptin, Nutrition, and Reproduction: Timing Is Everything
Hileman, S. M., Pierroz, D. D., & Flier, J. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6490 · Cited by 103 · see citing works
RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication
Yamamoto, Y., & Yamamoto, H. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00105 · Cited by 99 · see citing works
Self-citationCD38 and its role in oxytocin secretion and social behavior
Higashida, H., Yokoyama, S., Kikuchi, M., & Munesue, T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.011 · Cited by 98 · see citing works
Self-citationLeng, G., Pineda, R., Sabatier, N., & Ludwig, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0087 · Cited by 85 · see citing works
The many faces of oxytocin: Implications for psychiatry
Zik, J. B., & Roberts, D. L. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.048 · Cited by 85 · see citing works
Munesue, T., Nakamura, H., Kikuchi, M., Miura, Y., Takeuchi, N., Anme, T., Nanba, E., Adachi, K., Tsubouchi, K., Sai, Y., et al. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00002 · Cited by 84 · see citing works
Self-citationCai, Q., Feng, L., & Yap, K. Z. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12627 · Cited by 77 · see citing works
Psychopharmacological Interventions in Autism Spectrum Disorder
Politte, L. C., Henry, C. A., & McDougle, C. J. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000030 · Cited by 73 · see citing works
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
Xue, J., Manigrasso, M. B., Scalabrin, M., Rai, V., Reverdatto, S., Burz, D. S., Fabris, D., Schmidt, A. M., & Shekhtman, A. G. (2016) · Structure · doi:10.1016/j.str.2016.06.021 · Cited by 66 · see citing works
Rault, J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.015 · Cited by 63 · see citing works
RAGE mediates vascular injury and inflammation after global cerebral ischemia
Kamide, T., Kitao, Y., Takeichi, T., Okada, A., Mohri, H., Schmidt, A. M., Kawano, T., Munesue, S., Yamamoto, Y., Yamamoto, H., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.008 · Cited by 60 · see citing works
Self-citationTranslating Oxytocin Neuroscience to the Clinic: A National Institute of Mental Health Perspective
Insel, T. R. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.002 · Cited by 56 · see citing works
Quintana, D. S., Westlye, L. T., Smerud, K. T., Mahmoud, R. A., Andreassen, O. A., & Djupesland, P. G. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.05.004 · Cited by 52 · see citing works
Matsumoto, K., Chiba, Y., Fujihara, R., Kubo, H., Sakamoto, H., & Ueno, M. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1366-7 · Cited by 46 · see citing works
Takeuchi, A., Yamamoto, Y., Munesue, S., Harashima, A., Watanabe, T., Yonekura, H., Yamamoto, H., & Tsuchiya, H. (2013) · Cancer Science · doi:10.1111/cas.12133 · Cited by 46 · see citing works
Self-citationHigashida, H., Furuhara, K., Yamauchi, A.-M., Deguchi, K., Harashima, A., Munesue, S., Lopatina, O. L., Gerasimenko, M., Salmina, A. B., Zhang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07949-4 · Cited by 46 · see citing works
Self-citationRAGE mediates vascular injury and inflammation after global cerebral ischemia
上出, 智. (2012) · Medical Entomology and Zoology · Cited by 45 · see citing works
Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells
Yamamoto, Y., Yonekura, H., Watanabe, T., Sakurai, S., Li, H., Harashima, A., Myint, K. M., Osawa, M., Takeuchi, A., Takeuchi, M., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.030 · Cited by 44 · see citing works
Self-citationLandgraf, R., Ermisch, A., & Hess, J. (1979) · PubMed · Cited by 43 · see citing works
Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice
Sakatani, S., Yamada, K., Homma, C., Munesue, S., Yamamoto, Y., Yamamoto, H., & Hirase, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008309 · Cited by 42 · see citing works
Self-citationZhong, J., Amina, S., Liang, M., Akther, S., Yuhi, T., Nishimura, T., Tsuji, C., Tsuji, T., Liu, H.-X., Hashii, M., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00304 · Cited by 42 · see citing works
Self-citationVasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage
Martin, J., Kagerbauer, S. M., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2014) · Neuropeptides · doi:10.1016/j.npep.2013.12.004 · Cited by 40 · see citing works
Zhong, J., Liang, M., Akther, S., Higashida, C., Tsuji, T., & Higashida, H. (2014) · Molecular Brain · doi:10.1186/s13041-014-0066-x · Cited by 38 · see citing works
Self-citationGonzález, G. F., Žarić, G., Tijms, J., Bonte, M. L., & van der Molen, M. W. (2017) · Brain Sciences · doi:10.3390/brainsci7010010 · Cited by 31 · see citing works
Lopatina, O. L., Furuhara, K., Ishihara, K., Salmina, A. B., & Higashida, H. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00266 · Cited by 30 · see citing works
Self-citationMens, W. B. J., Laczi, F., Tonnaer, J. A. D. M., de Kloet, E. R., & Greidanus, T. B. V. W. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90332-5 · Cited by 29 · see citing works
Carter, C. S. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_18 · Cited by 25 · see citing works
Effects of Three Lipidated Oxytocin Analogs on Behavioral Deficits in CD38 Knockout Mice
Михайлович, Ч. С., Akther, S., Nishimura, T., Shabalova, A. A., Mizuno, A., Ichinose, W., Shuto, S., Yamamoto, Y., Yokoyama, S., & Higashida, H. (2017) · Brain Sciences · doi:10.3390/brainsci7100132 · Cited by 23 · see citing works
Self-citationMotoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., & Yamamoto, H. (2014) · Biochemical Journal · doi:10.1042/bj20140084 · Cited by 20 · see citing works
Self-citationIncreased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs
Temesi, A., Thuróczy, J., Balogh, L., & Miklósi, Á. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00147 · Cited by 18 · see citing works
Martinez, L. A., Levy, M. J., & Petrulis, A. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.08.016 · Cited by 11 · see citing works
Saito, R., Araki, S., Yamamoto, Y., & Kusuhara, K. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0262 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
1 of the 84 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Is oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394 · see citing works
Quintana, D. S., Lischke, A., Grace, S., Scheele, D., Ma, Y., & Becker, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00864-7 · Cited by 263 · see citing works
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194 · see citing works
Challenges for measuring oxytocin: the blind men and the elephant?
MacLean, E. L., Wilson, S. R., Martin, W. L., Davis, J. M., Nazarloo, H. P., & Carter, C. S. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.05.018 · Cited by 183 · see citing works
RAGE signaling regulates the progression of diabetic complications
Taguchi, K., & Fukami, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1128872 · Cited by 144 · see citing works
Oxytocin and postpartum depression: A systematic review
Thul, T. A., Corwin, E. J., Carlson, N. S., Brennan, P. A., & Young, L. J. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104793 · Cited by 142 · see citing works
Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques
Lee, M. R., Shnitko, T. A., Blue, S. W., Kaucher, A. V., Winchell, A. J., Erikson, D. W., Grant, K. A., & Leggio, L. (2020) · Nature Communications · doi:10.1038/s41467-020-15942-1 · Cited by 132 · see citing works
Martins, D., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A. E., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14845-5 · Cited by 130 · see citing works
Bertoni, A., Schaller, F., Tyzio, R., Gaillard, S., Santini, F., Xolin, M., Diabira, D., Vaidyanathan, R., Matarazzo, V. A., Medina, I., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01227-6 · Cited by 110 · see citing works
The transition to motherhood: linking hormones, brain and behaviour
Servin-Barthet, C., Martínez‐Garcia, M., Pretus, C., Paternina-Die, M., Soler, A., Khymenets, O., Pozo, Ó. J., Leuner, B., Vilarroya, Ó., & Carmona, S. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00733-6 · Cited by 105 · see citing works
RAGE regulates oxytocin transport into the brain
Yamamoto, Y., & Higashida, H. (2020) · Communications Biology · doi:10.1038/s42003-020-0799-2 · Cited by 106 · see citing works
Self-citationOxytocin and Stress: Neural Mechanisms, Stress-Related Disorders, and Therapeutic Approaches
Matsushita, H., Latt, H. M., Koga, Y., Nishiki, T., & Matsui, H. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.046 · Cited by 92 · see citing works
Morofuji, Y., & Nakagawa, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200224112534 · Cited by 83 · see citing works
Lopatina, O. L., Malinovskaya, N. A., Komleva, Y. K., Gorina, Y. V., Shuvaev, A. N., Olovyannikova, R. Y., Belozor, O. S., Belova, O. A., Higashida, H., & Salmina, A. B. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0014 · Cited by 74 · see citing works
Self-citationThe role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders
Abramova, O. V., Zorkina, Y., Ushakova, V. M., Zubkov, E. A., Morozova, A. Y., & Chekhonin, V. P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102079 · Cited by 74 · see citing works
Numan, M. (2020) · doi:10.1093/oso/9780190848675.001.0001 · Cited by 101 · see citing works
CD38, CD157, and RAGE as Molecular Determinants for Social Behavior
Higashida, H., Hashii, M., Tanaka, Y., Matsukawa, S., Higuchi, Y., Gabata, R., Tsubomoto, M., Seishima, N., Teramachi, M., Kamijima, T., et al. (2019) · Cells · doi:10.3390/cells9010062 · Cited by 58 · see citing works
Self-citationHigashida, H., Munesue, T., Kosaka, H., Yamasue, H., Yokoyama, S., & Kikuchi, M. (2019) · Diseases · doi:10.3390/diseases7010024 · Cited by 64 · see citing works
Self-citationOxytocin in the anterior cingulate cortex is involved in helping behaviour
Yamagishi, A., Lee, J., & Sato, N. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112790 · Cited by 50 · see citing works
Yao, S., & Kendrick, K. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020323 · Cited by 52 · see citing works
The neuropeptide landscape of human prefrontal cortex
Zhong, W., Barde, S. S., Mitsios, N., Ádori, C., Oksvold, P., von Feilitzen, K., O’Leary, L. A., Csiba, L., Hortobágyi, T., Szocsics, P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123146119 · Cited by 49 · see citing works
Buckley, S. J., Uvnäs‐Moberg, K., Pajalić, Z., Luegmair, K., Ekström, A., Dencker, A., Massarotti, C., Kotłowska, A., Callaway, L. K., Morano, S., et al. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05221-w · Cited by 58 · see citing works
Everett, N. A., Turner, A. J., Costa, P. A., Baracz, S. J., & Cornish, J. L. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0719-7 · Cited by 52 · see citing works
Oxytocin—a social peptide? Deconstructing the evidence
Leng, G., Leng, R., & Ludwig, M. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0055 · Cited by 48 · see citing works
Prolactin and oxytocin: potential targets for migraine treatment
Szewczyk, A. K., Ulutas, S., Aktürk, T., Al‐Hassany, L., Börner, C., Cernigliaro, F., Kodounis, M., Cascio, S. L., Mikolajek, D., Onan, D., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01557-6 · Cited by 48 · see citing works
How does oxytocin modulate human behavior?
Yao, S., & Kendrick, K. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02898-1 · Cited by 55 · see citing works
Everett, N. A., Baracz, S. J., & Cornish, J. L. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0566-6 · Cited by 48 · see citing works
Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin
Panaro, M. A., Benameur, T., & Porro, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051534 · Cited by 48 · see citing works
Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry
Ford, C. L., & Young, L. J. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.11.007 · Cited by 46 · see citing works
Transcriptional Profiling of the Murine Airway Response to Acute Ozone Exposure
Tovar, A., Smith, G. J., Thomas, J. M., Crouse, W. L., Harkema, J. R., & Kelada, S. N. P. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz219 · Cited by 41 · see citing works
Role of RAGE in the Pathogenesis of Neurological Disorders
Juranek, J., Mukherjee, K., Kordas, B., Załęcki, M., Korytko, A., Zglejc-Waszak, K., Szuszkiewicz, J., & Banach, M. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00878-x · Cited by 45 · see citing works
Martins, D., Paduraru, M., & Paloyelis, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15451 · Cited by 43 · see citing works
Oxytocin Receptor Signaling in Vascular Function and Stroke
McKay, E. C., & Counts, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574499 · Cited by 41 · see citing works
Gerasimenko, M., Михайлович, Ч. С., Furuhara, K., Lopatina, O. L., Salmina, A. B., Shabalova, A. A., Tsuji, C., Yokoyama, S., Ishihara, K., Brenner, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57236-7 · Cited by 40 · see citing works
Self-citationYeomans, D. C., Hanson, L. R., Carson, D. S., Tunstall, B. J., Lee, M. R., Tzabazis, A., Jacobs, D. L., & Frey, W. H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01511-7 · Cited by 40 · see citing works
A Novel Role of CD38 and Oxytocin as Tandem Molecular Moderators of Human Social Behavior
Tolomeo, S., Chiao, B., Lei, Z., Chew, S. H., & Ebstein, R. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.013 · Cited by 39 · see citing works
Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Iovino, M., Messana, T., Tortora, A., Giusti, C., Lisco, G., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., & Triggiani, V. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200520093730 · Cited by 39 · see citing works
Sniffing oxytocin: Nose to brain or nose to blood?
Yao, S., Chen, Y., Zhuang, Q., Zhang, Y., Lan, C., Zhu, S., Becker, B., & Kendrick, K. M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02075-2 · Cited by 38 · see citing works
Kou, J., Lan, C., Zhang, Y., Wang, Q., Zhou, F., Zhao, Z., Montag, C., Yao, S., Becker, B., & Kendrick, K. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01241-w · Cited by 37 · see citing works
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y.-A., Wu, T., Chen, C.-H., & Lu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137092 · Cited by 37 · see citing works
Intertwined associations between oxytocin, immune system and major depressive disorder
Jiang, J., Yang, M., Tian, M., Chen, Z., Xiao, L., & Gong, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114852 · Cited by 36 · see citing works
Interplay between the oxytocin and opioid systems in regulating social behaviour
Putnam, P. T., & Chang, S. W. C. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0050 · Cited by 33 · see citing works
The impact of oxytocin on neurite outgrowth and synaptic proteins in Magel2 ‐deficient mice
Reichova, A., Schaller, F., Bukatová, S., Bačová, Z., Muscatelli, F., & Bakoš, J. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22815 · Cited by 35 · see citing works
Munesue, S., Liang, M., Harashima, A., Zhong, J., Furuhara, K., Boitsova, E. B., Михайлович, Ч. С., Gerasimenko, M., Yuhi, T., Yamamoto, Y., et al. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12963 · Cited by 32 · see citing works
Self-citationGnanadesikan, G. E., Hammock, E. A. D., Tecot, S. R., Carter, C. S., & MacLean, E. L. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105368 · Cited by 29 · see citing works
Fear, love, and the origins of canid domestication: An oxytocin hypothesis
Herbeck, Y. E., Eliava, M., Grinevich, V., & MacLean, E. L. (2021) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2021.100100 · Cited by 29 · see citing works
The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders
Jin, Y., Song, D. F., Yan, Y., Quan, Z., & Qing, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310430 · Cited by 30 · see citing works
Shimizu, Y., Harashima, A., Munesue, S., Oishi, M., Hattori, T., Hori, O., Kitao, Y., Yamamoto, H., Leerach, N., Nakada, M., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0715 · Cited by 28 · see citing works
Self-citationTherapeutic uses of oxytocin in stress-related neuropsychiatric disorders
Zhang, S., Zhang, Y., Shi, D., & Wang, Z. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01173-6 · Cited by 28 · see citing works
Leerach, N., Harashima, A., Munesue, S., Kimura, K., Oshima, Y., Goto, H., Yamamoto, H., Higashida, H., & Yamamoto, Y. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09956-6 · Cited by 27 · see citing works
Self-citationKITAUCHI, S., Maeda, M., Hirano, T., Ikenaka, Y., NISHI, M., SHODA, A., MURATA, M., MANTANI, Y., YOKOYAMA, T., Tabuchi, Y., et al. (2021) · Journal of Veterinary Medical Science · doi:10.1292/jvms.21-0014 · Cited by 27 · see citing works
Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention
Zhuang, Q., Zheng, X., Yao, S., Zhao, W., Becker, B., Xu, X., & Kendrick, K. M. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac059 · Cited by 26 · see citing works
Gasparotto, J., Somensi, N., Girardi, C. S., Bittencourt, R. R., de Oliveira, L. M., Hoefel, L. P. L., Scheibel, I. M., Peixoto, D. O., Moreira, J. C. F., Outeiro, T. F., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15890 · Cited by 26 · see citing works
Oxytocin ameliorates impaired social behavior in a Chd8 haploinsufficiency mouse model of autism
Михайлович, Ч. С., Gerasimenko, M., Yuhi, T., Furuhara, K., Tsuji, C., Yokoyama, S., Nakayama, K. I., Nishiyama, M., & Higashida, H. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00631-6 · Cited by 24 · see citing works
Self-citationAlcohol and oxytocin: Scrutinizing the relationship
Ryabinin, A. E., & Fulenwider, H. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.009 · Cited by 23 · see citing works
Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review
Houghton, B., Kouimtsidis, C., Duka, T., Paloyelis, Y., & Bailey, A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15617 · Cited by 23 · see citing works
Quintana, D. S. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105642 · Cited by 21 · see citing works
Lefter, R. M., Ciobica, A. S., Antioch, I., Ababei, D. C., Hrițcu, L. D., & Luca, A.-C. (2020) · Medicina · doi:10.3390/medicina56060267 · Cited by 22 · see citing works
Discussions and perspectives regarding oxytocin as a biomarker in human investigations
Mera, J. C. C., Molano, M. A. C., López, C. C. G., Triana, C. A., & Cotrina, J. A. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08289 · Cited by 21 · see citing works
Walcott, A. T., & Ryabinin, A. E. (2020) · Addiction Biology · doi:10.1111/adb.12893 · Cited by 21 · see citing works
Watanabe, D., Nakagawa, S., Morofuji, Y., Tóth, A. E., Vastag, M., Aruga, J., Niwa, M., & Deli, M. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091484 · Cited by 20 · see citing works
The neurobiology of parenting and infant-evoked aggression
Kaplan, H. S., Horvath, P. M., Rahman, M. M., & Dulac, C. G. (2024) · Physiological Reviews · doi:10.1152/physrev.00036.2023 · Cited by 20 · see citing works
Caruso, M. A., Robins, M. T., Fulenwider, H. D., & Ryabinin, A. E. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05741-3 · Cited by 19 · see citing works
Makris, G., Chouliaras, G. L., Apostolakou, F., Papageorgiou, C., Chrousos, G. P., Papassotiriou, I., & Pervanidou, P. (2021) · Children · doi:10.3390/children8060478 · Cited by 18 · see citing works
Oxytocin measurements in saliva: an analytical perspective
López-Arjona, M., Botia, M., Martı́nez-Subiela, S., & Cerón, J. M. C. (2023) · BMC Veterinary Research · doi:10.1186/s12917-023-03661-w · Cited by 18 · see citing works
Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories
Parmaksiz, D., & Kim, Y. (2024) · The Neuroscientist · doi:10.1177/10738584241268754 · Cited by 20 · see citing works
Potretzke, S., Zhang, Y., Li, J., Fecteau, K. M., Erikson, D. W., Hibert, M., & Ryabinin, A. E. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01490-3 · Cited by 16 · see citing works
Kamynina, A. V., Esteras, N., Koroev, D. O., Angelova, P. R., Volpina, O. M., & Abramov, A. Y. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30324 · Cited by 16 · see citing works
Brackley, A. D., & Toney, G. M. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000535 · Cited by 14 · see citing works
Oxytocin modulates local topography of human functional connectome in healthy men at rest
Martins, D., Dipasquale, O., & Paloyelis, Y. (2021) · Communications Biology · doi:10.1038/s42003-020-01610-z · Cited by 15 · see citing works
Microbes, oxytocin and stress: Converging players regulating eating behavior
Cuesta‐Marti, C., Uhlig, F., Muguerza, B., Hyland, N. P., Clarke, G. A., & Schellekens, H. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13243 · Cited by 15 · see citing works
Oxytocin and CD38 in the paraventricular nucleus play a critical role in paternal aggression in mice
Shabalova, A. A., Liang, M., Zhong, J., Huang, Z., Tsuji, C., Shnayder, N. A., Lopatina, O. L., Salmina, A. B., Okamoto, H., Yamamoto, Y., et al. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104695 · Cited by 18 · see citing works
Self-citationXu, D., Li, Q., Zhuang, Q., Zhang, Y., Yao, S., Zhao, W., & Kendrick, K. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1022101 · Cited by 13 · see citing works
Lan, C., Chen, Y., Zhang, Y., Kou, J., Huang, L., Xu, T., Yang, X., Xu, D., Yang, W., Kendrick, K. M., et al. (2023) · Neuroendocrinology · doi:10.1159/000531064 · Cited by 12 · see citing works
D’Aniello, B., Mastellone, V., Pinelli, C., Scandurra, A., Musco, N., Tudisco, R., Pero, M. E., Infascelli, F., Lucrezia, A. D., & Lombardi, P. (2022) · Animals · doi:10.3390/ani12030276 · Cited by 12 · see citing works
Higashida, H., Furuhara, K., Lopatina, O. L., Gerasimenko, M., Hori, O., Hattori, T., Hayashi, Y., Михайлович, Ч. С., Shabalova, A. A., Salmina, A. B., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858070 · Cited by 13 · see citing works
Self-citationLi, L., Li, P., Guo, J., Wu, Y., Zeng, Q., Li, N., Huang, X., He, Y., Ai, W., Sun, W., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16042 · Cited by 12 · see citing works
Hohl, C. H., Zilcha‐Mano, S., & Delgadillo, J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105935 · Cited by 12 · see citing works
Gerasimenko, M., Lopatina, O., Munesue, S., Harashima, A., Yokoyama, S., Yamamoto, Y., & Higashida, H. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113395 · Cited by 11 · see citing works
Self-citationHu, S., Wang, Y., Han, X., Dai, M., Zhang, Y., Ma, Y., Weng, S.-J., & Xiao, L. (2022) · BMC Biology · doi:10.1186/s12915-022-01405-0 · Cited by 11 · see citing works
Maejima, Y., Yokota, S., Hidema, S., Nishimori, K., de Wet, H., & Shimomura, K. (2024) · Neuroendocrinology · doi:10.1159/000538792 · Cited by 11 · see citing works
Self-citationHayashi, K., Sato, K., Ochi, S., Kawano, S., Munesue, S., Harashima, A., Oshima, Y., Kimura, K., Kyoi, T., & Yamamoto, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105757 · Cited by 10 · see citing works
Self-citationMeasuring salivary mesotocin in birds - Seasonal differences in ravens' peripheral mesotocin levels
Stocker, M., Prosl, J., Vanhooland, L., Horn, L., Bugnyar, T., Canoine, V., & Massen, J. J. M. (2021) · Hormones and Behavior · doi:10.1016/j.yhbeh.2021.105015 · Cited by 10 · see citing works
Rybicka, M., Kaźmierczak, M., Pawlicka, P., Łada‐Maśko, A., Anikiej‐Wiczenbach, P., & Bielawski, K. P. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105294 · Cited by 10 · see citing works
Manjila, S. B., Betty, R., & Kim, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1044736 · Cited by 11 · see citing works
Human social behavior and oxytocin: Molecular and neuronal mechanisms
Matsushita, H., & Nishiki, T. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.026 · Cited by 11 · see citing works
Higashida, H., Oshima, Y., & Yamamoto, Y. (2024) · Peptides · doi:10.1016/j.peptides.2024.171230 · Cited by 9 · see citing works
Self-citationOral oxytocin delivery with proton pump inhibitor pretreatment decreases food intake
Maejima, Y., Horita, S., Otsuka, A., Hidema, S., Nishimori, K., & Shimomura, K. (2020) · Peptides · doi:10.1016/j.peptides.2020.170312 · Cited by 9 · see citing works
Self-citationDual Nature of RAGE in Host Reaction and Nurturing the Mother–Infant Bond
Oshima, Y., Harashima, A., Munesue, S., Kimura, K., Leerach, N., Goto, H., Tanaka, M. H., Niimura, A., Hayashi, K., Yamamoto, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042086 · Cited by 9 · see citing works
Self-citationMartins, D. A., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563056 · Cited by 9 · see citing works
PVN-mPFC OT projections modulate pup-directed pup care or attacking in virgin mandarin volesPreprint
Li, L., Li, Y., Huang, C.-H., Hou, W.-J., Lv, Z., Zhang, L.-Z., Qu, Y., Sun, Y., Huang, K., Han, X., et al. (2024) · eLife · doi:10.7554/elife.96543 · Cited by 7 · see citing works
Yamamoto, Y., Zhang, A., Yuhi, T., Harashima, A., Shabalova, A. A., Nishizawa, E., Moriya, M., Munesue, S., Oshima, Y., Gerasimenko, M., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152004 · Cited by 8 · see citing works
Self-citationTakeda, R., Demura, M., Sugimura, Y., Miyamori, I., Konoshita, T., & Yamamoto, H. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0745 · Cited by 8 · see citing works
Self-citationBarriers and Breakthroughs in Targeting the Oxytocin System to Treat Alcohol Use Disorder
Ryabinin, A. E., & Zhang, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.842609 · Cited by 8 · see citing works
Empathy in stroke rats is modulated by social settings
Shinozuka, K., Tajiri, N., Ishikawa, H., Tuazon, J. P., Lee, J.-Y., Sanberg, P. R., Zarriello, S., Corey, S., Kaneko, Y., & Borlongan, C. V. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19867908 · Cited by 8 · see citing works
Mahmuda, N. A., Yokoyama, S., Munesue, T., Hayashi, K., Yagi, K., Tsuji, C., & Higashida, H. (2020) · Diseases · doi:10.3390/diseases8010004 · Cited by 8 · see citing works
Self-citationLopatina, O. L., Morgun, A. V., Gorina, Y. V., Salmin, V. V., & Salmina, A. B. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108616 · Cited by 8 · see citing works
Self-citationInfant Stimulation Induced a Rapid Increase in Maternal Salivary Oxytocin
Minami, K., Yuhi, T., Higashida, H., Yokoyama, S., Tsuji, T., & Tsuji, C. (2022) · Brain Sciences · doi:10.3390/brainsci12091246 · Cited by 7 · see citing works
Self-citationA monoclonal antibody raised against a synthetic oxytocin peptide stains mouse hypothalamic neurones
Kogami, Y., Tsuji, T., Tsuji, C., Yokoyama, S., Furuhara, K., Lopatina, O. L., Shabalova, A. A., Salmina, A. B., Watanabe, Y., Hattori, T., et al. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12815 · Cited by 7 · see citing works
Self-citationGuebel, D. V., Torres, N. V., & Acebes, Á. (2021) · Biology Open · doi:10.1242/bio.057950 · Cited by 6 · see citing works
- Authors
- Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., Eguchi, Y., Kitao, Y., Hori, O., Shiraishi, Y., Ozaki, N., Shimizu, Y., Kamide, T., Yoshikawa, A., Hayashi, Y., Nakada, M., Lopatina, O., Gerasimenko, M., Komleva, Y., Malinovskaya, N., Salmina, A. B., Asano, M., Nishimori, K., Shoelson, S. E., Yamamoto, H., & Higashida, H.
- Affiliations
- Kanazawa University (JP)
- Kanazawa Medical University (JP)
- Krasnoyarsk State Medical University (RU)
- Tohoku University (JP)
- Joslin Diabetes Center (US)
- Corresponding author
- Yamamoto, Yasuhiko
- Higashida, Haruhiro
- ORCID
- Yamamoto, Yasuhiko
- Liang, Mingkun
- Yuhi, Teruko
- Zhong, Jing
- Goto, Hisanori
- Hori, Osamu
- Shimizu, Yu
- Kamide, Tomoya
- Yoshikawa, Akifumi
- Hayashi, Yasuhiko
- Nakada, Mitsutoshi
- Lopatina, Olga
- Gerasimenko, Maria
- Komleva, Yulia
- Malinovskaya, Natalia
- Salmina, Alla B.
- Asano, Masahide
- Nishimori, Katsuhiko
- Shoelson, Steven E.
- Higashida, Haruhiro
- Venue
- Communications Biology
- Published
- 2019-02-25
- Volume
- 2
- Issue
- 1
- Pages
- 76-76
- ISSN
- 2399-3642 (ISSN-L)
- PMC
- PMC6389896
- OpenAlex
- W2915217457
- Semantic Scholar
- 15105180d45078885146968dd9ad52c15161b461
- Cited by
- 171
- References
- 84
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 13 · 2023: 17 · 2022: 23 · 2021: 40 · 2020: 44 · 2019: 11
- FWCI
- 37.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Communications Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Kanazawa University
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (17K09031, 18K06889, 25461335, 18KK0255, 24590375, 18K06500, 18K07551)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK036836)
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- oxytocin, receptor for advanced glycation end products, RAGE, blood-brain barrier, brain microvascular endothelial cells, maternal behavior, social bonding, hyperactivity, oxytocin receptor
- MeSH terms
- Receptor for Advanced Glycation End Products, Animals, Brain, Female, Humans, Male, Maternal Behavior, Mice, Inbred C57BL, Mice, Transgenic, Object Attachment, Oxytocin, Receptors, Oxytocin, Mice, Knockout, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review